Jin Long Chen - Dec 6, 2021 Form 4 Insider Report for NGM BIOPHARMACEUTICALS INC (NGM)

Role
Chief Scientific Officer, Director
Signature
/s/ Jin-Long Chen
Stock symbol
NGM
Transactions as of
Dec 6, 2021
Transactions value $
-$452,151
Form type
4
Date filed
12/7/2021, 08:54 PM
Previous filing
Nov 16, 2021
Next filing
Mar 4, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NGM Common Stock Sale -$273K -15K -1.73% $18.21* 854K Dec 6, 2021 Direct F1, F2
transaction NGM Common Stock Options Exercise $100K +69.4K +8.13% $1.44 924K Dec 6, 2021 Direct
transaction NGM Common Stock Sale -$279K -15K -1.62% $18.60* 909K Dec 7, 2021 Direct F1, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NGM Stock Option (Right to Buy) Options Exercise $0 -69.4K -44.94% $0.00 85.1K Dec 6, 2021 Common Stock 69.4K $1.44 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 6, 2021.
F2 Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $17.79 to $18.49. The reporting person has provided to the issuer, and undertakes to provide to the staff of the Commission or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range.
F3 Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $18.10 to $18.99. The reporting person has provided to the issuer, and undertakes to provide to the staff of the Commission or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range.
F4 Fully vested.